NewsBenzingaLipocine: utile per azione del terzo trimestre $(0,08), supera la stima di $(0,32); vendite a $2,290 milioni, superano la stima di $159.500 mila. Lipocine: utile per azione del terzo trimestre $(0,08), supera la stima di $(0,32); vendite a $2,290 milioni, superano la stima di $159.500 mila. Benzinga 2026.11.05 13:23 (GMT+0) Open on Benzinga Other news ElevenLabs now lets users publish AI-generated music directly on SoundCloud Instagram brings Edits to desktop to take on CapCut Tesla and SpaceX Fall 10% and 7% Respectively Colgate-Palmolive Stock Outlook: Is Wall Street Bullish or Bearish? Dear Future Agility Robotics Stock Investors, Mark Your Calendars for November 5 Aina’s smart ring has a screen, a joystick and a mic so you can talk to AI agents
